Utama › Kanser Payudara › California › San Francisco
Kajian klinikal Kanser Payudara di San Francisco, CA
43 kajian untuk Kanser Payudara sedang mencari peserta di lokasi dalam dan sekitar San Francisco (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Mengambil pesertaFasa 1/2
- Research Site, San Francisco
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Mengambil pesertaFasa 3
- University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, San Francisco
Distance-Based Exercise to Preserve Function and Prevent Disability
Mengambil peserta
- Kaiser Permanente-San Francisco, San Francisco
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Mengambil pesertaFasa 2
- University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, San Francisco
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Mengambil pesertaFasa 3
- Clinical Trial Site, San Francisco
- Clinical Trial Site, San Francisco
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Mengambil pesertaFasa 3
- Kaiser Permanente, San Francisco
- UCSF Medical Center at Mission Bay, San Francisco
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
Mengambil pesertaSukarelawan sihat dialu-alukan
- University of California San Francisco, San Francisco
Pulsed Electric Field Ablation for Metastatic Breast Cancer
Mengambil peserta
- University of California San Francisco, San Francisco
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Mengambil pesertaFasa 3
- UCSF Zuckerberg SF General, San Francisco
- University of California, San Francisco (UCSF), San Francisco
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
Mengambil pesertaFasa 1
- UCSF Medical Center at Mission Bay, San Francisco
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Mengambil pesertaFasa 1/2
- UCSF Helen Diller Family CCC, San Francisco
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Mengambil pesertaFasa 1/2
- University of California, San Francisco, San Francisco
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- University of California-San Fransisco, San Francisco
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
Mengambil pesertaKajian pemerhatian
- University of California, San Francisco, San Francisco
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Mengambil pesertaFasa 3
- California Pacific Medical Center-Pacific Campus, San Francisco
- Kaiser Permanente-San Francisco, San Francisco
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
Mengambil pesertaFasa 2
- University of San Francisco, San Francisco
ATEMPT 2.0: Adjuvant T-DM1 vs TH
Mengambil pesertaFasa 2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer
Mengambil pesertaFasa 2
- University of California San Francisco, San Francisco
Generative AI Patient Education Module for Breast Oncology
Mengambil peserta
- University of California, San Francisco, San Francisco
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Mengambil pesertaFasa 3
- University of California San Francisco - Helen Diller Family Comprehensive Cancer Center, San Francisco
E-Mindfulness Approaches for Living After Breast Cancer
Mengambil pesertaFasa 3
- Kaiser Permanente-San Francisco, San Francisco
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Mengambil pesertaFasa 2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- UCSF Medical Center at Mission Bay, San Francisco
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Mengambil pesertaFasa 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Magnetic Resonance Imaging in Radiotherapy for Breast Cancer
Mengambil pesertaKajian pemerhatian
- University of California, San Francisco, San Francisco
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial
Mengambil pesertaFasa 3
- University of California at San Francisco, San Francisco
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Mengambil pesertaFasa 2
- University of California San Francisco (UCSF), San Francisco
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
Mengambil pesertaFasa 2
- UCSF Medical Center-Mission Bay/Benioff Children's Hospital, San Francisco
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
Mengambil pesertaFasa 2
- University of California San Francisco, San Francisco
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Mengambil peserta
- Zuckerberg San Francisco General, San Francisco
- Kaiser Foundation Research Institute, San Francisco
- University of San Francisco, San Francisco
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Mengambil pesertaFasa 3
- California Pacific Medical Center-Pacific Campus, San Francisco
- Kaiser Permanente-San Francisco, San Francisco
Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction
Mengambil pesertaKajian pemerhatian
- University of California, San Francisco
Microbiome and Association With Implant Infections
Mengambil pesertaFasa 2
- University of California, San Francisco, San Francisco
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Mengambil pesertaKajian pemerhatian
- Kaiser Permanente-San Francisco, San Francisco
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
Mengambil pesertaFasa 2
- University of California San Francisco (Data collection only), San Francisco
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Mengambil pesertaFasa 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Mengambil pesertaFasa 1
- University of California San Francisco, San Francisco
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
Mengambil peserta
- UCSF Breast Care Center, San Francisco
Patient Care Outreach, Navigation, Technology and Support 2.0
Mengambil peserta
- Zuckerberg San Francisco General Hospital, San Francisco
- University of California, San Francisco, San Francisco
Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- University of California, San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, San Francisco
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Mengambil pesertaKajian pemerhatian
- UCSF Breast Care Center, San Francisco
Kajian Kanser Payudara di bandar lain
- New York City, NY136 kajian
- Houston, TX126 kajian
- Boston, MA112 kajian
- Nashville, TN81 kajian
- Los Angeles, CA73 kajian
- Edison, NJ68 kajian
- St. Louis, MO64 kajian
- Queens, NY64 kajian
- Durham, NC64 kajian
- Chicago, IL59 kajian
- Philadelphia, PA56 kajian
- Dallas, TX55 kajian
Kajian lain di San Francisco
- Kanser Prostat45 kajian
- Kanser Paru-paru Bukan Sel Kecil36 kajian
- Kanser (semua jenis)35 kajian
- Kegagalan Jantung29 kajian
- Kanser Metastatik28 kajian
- Kanser Paru-paru22 kajian
- Melanoma22 kajian
- Kanser Pankreas20 kajian
- Kanser Ovari19 kajian
- Kanser Kolorektal18 kajian
- Penyakit Kardiovaskular18 kajian
- Glioblastoma17 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.